Td Waterhouse Canada Inc. Imv Inc. Transaction History

Td Waterhouse Canada Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Nov 13, 2023	SELL	$0.22 - $3.64 $6,109 - $101,079	-27,769 Closed	0 $0
Q2 2022 Nov 13, 2023	SELL	$0.56 - $1.45 $3,920 - $10,150	-7,000 Reduced 20.13%	27,769 $23.7 Million
Q1 2022 Nov 13, 2023	BUY	$1.07 - $1.5 $14,177 - $19,875	13,250 Added 61.57%	34,769 $60.2 Million
Q4 2021 Nov 13, 2023	BUY	$1.22 - $1.78 $26,253 - $38,303	21,519 New	21,519 $35.5 Million

Ticker IMV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,452,200
Description
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

Stay updated on Td Waterhouse Canada Inc. with notifications on news.